| Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers (NCT05353179) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-01 |
| Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia. (NCT05703802) | University Hospital Muenster | 2022-02-01 |
| Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA (NCT04944524) | Shanghai Zhongshan Hospital | 2021-07-01 |
| Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (NCT05716334) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-06-15 |
| Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study (NCT03182049) | Vanderbilt University Medical Center | 2020-12-01 |
| PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis (NCT04280601) | Christian Pagnoux | 2020-08-01 |
| TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis (NCT03919435) | University of Pennsylvania | 2019-03-27 |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (NCT03482479) | University of Pennsylvania | 2019-02-04 |
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis (NCT03967925) | Rachel Jones | 2019-02-01 |
| Journey of Patients With Vasculitis From First Symptom to Diagnosis (NCT03410290) | University of Pennsylvania | 2018-01-11 |
| Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (NCT02108860) | University of South Florida | 2015-04-25 |
| BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis (NCT01598857) | Anthera Pharmaceuticals | 2014-12-01 |
| Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis (NCT02169219) | Massachusetts General Hospital | 2014-06-01 |
| Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis (NCT02126098) | Peking Union Medical College Hospital | 2014-05-01 |
| The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach (NCT01933724) | University of South Florida | 2014-02-17 |
| The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach (NCT01940094) | University of Pennsylvania | 2014-02-01 |
| A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis (NCT01750697) | Hoffmann-La Roche | 2013-05-23 |
| Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis (NCT01731561) | Assistance Publique - Hôpitaux de Paris | 2012-11-16 |
| An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis (NCT01613599) | Genentech, Inc. | 2012-06-20 |
| Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) (NCT01862068) | Assistance Publique - Hôpitaux de Paris | 2012-05-25 |
| Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study (NCT01586858) | Johns Hopkins University | 2012-05-01 |
| Alemtuzumab for ANCA Associated Refractory Vasculitis (NCT01405807) | Cambridge University Hospitals NHS Foundation Trust | 2011-02-01 |
| Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis (NCT03782870) | Medical University of Warsaw | 2010-02-01 |
| Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis (NCT00315393) | University of Pennsylvania | 2006-04-01 |